4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001104659-22-011517
Chief Scientific Officer gave up 2,183 shares (to pay taxes)
- Chief Scientific Officer acquired 2,106 shares (grant or award)
- Chief Scientific Officer acquired 6,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roberts M Scot · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-31 | Grant or award : show line 1 in the form | +2,106 | $6.86 | $14,447 | 13,717 | D |
| 2022-02-01 | Exercise or conversion : show line 2 in the form | +6,166 | 19,883 | D | ||
| 2022-02-01 | Shares withheld for taxes : show line 3 in the form | −2,183 | $7.98 | $17,420 | 17,700 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-01 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −6,166 | 18,498 | D |
| 2022-02-02 | Grant or award : show line 5 in the form Stock Options (option to buy) | +91,600 | 91,600 | D |
| 2022-02-02 | Grant or award : show line 6 in the form Restricted Stock Units | +31,100 | 31,100 | D |
Loading xslF345X03/tm225504-1_4seq1.xml…